Citius Pharmaceuticals Inc (CTXR)
0.3284
-0.06
(-14.86%)
USD |
NASDAQ |
Nov 14, 16:00
0.33
0.00 (0.00%)
Pre-Market: 08:39
Citius Pharmaceuticals Cash and Short Term Investments (Quarterly): 17.91M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.91M |
| March 31, 2024 | 12.56M |
| December 31, 2023 | 20.35M |
| September 30, 2023 | 26.48M |
| June 30, 2023 | 33.28M |
| March 31, 2023 | 29.07M |
| December 31, 2022 | 36.89M |
| September 30, 2022 | 41.71M |
| June 30, 2022 | 48.04M |
| March 31, 2022 | 55.76M |
| December 31, 2021 | 65.42M |
| September 30, 2021 | 70.07M |
| June 30, 2021 | 115.66M |
| March 31, 2021 | 103.70M |
| December 31, 2020 | 4.296M |
| September 30, 2020 | 13.86M |
| June 30, 2020 | 8.517M |
| March 31, 2020 | 4.339M |
| December 31, 2019 | 2.780M |
| September 30, 2019 | 7.894M |
| June 30, 2019 | 4.511M |
| March 31, 2019 | 3.199M |
| December 31, 2018 | 7.042M |
| September 30, 2018 | 9.184M |
| June 30, 2018 | 2.762M |
| Date | Value |
|---|---|
| March 31, 2018 | 5.008M |
| December 31, 2017 | 7.371M |
| September 30, 2017 | 3.204M |
| June 30, 2017 | 0.1987M |
| March 31, 2017 | 0.0611M |
| December 31, 2016 | 0.0468M |
| September 30, 2016 | 0.2944M |
| June 30, 2016 | 1.626M |
| March 31, 2016 | 3.759M |
| December 31, 2015 | 0.2815M |
| September 30, 2015 | 0.6761M |
| June 30, 2015 | 0.951M |
| March 31, 2015 | 0.7604M |
| December 31, 2014 | 0.8172M |
| September 30, 2014 | 1.552M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0001M |
| December 31, 2012 | 0.0001M |
| September 30, 2012 | 0.0001M |
| June 30, 2012 | 0.0002M |
| March 31, 2012 | 0.00 |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.780M
Minimum
Dec 2019
115.66M
Maximum
Jun 2021
37.40M
Average
29.07M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Agilent Technologies Inc | 1.779B |
| Seelos Therapeutics Inc | 0.294M |
| Cara Therapeutics Inc | 56.62M |
| Moleculin Biotech Inc | 9.405M |
| Citius Oncology Inc | -- |